Biomea Fusion, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of irreversible small molecules to treat patients with genetically defined cancers. The company was formed in 2017 by a small group of biotech executives that came together with the common goal of achieving better therapies for patients.

Biotechnology

biomea fusion

Thomas Butler

Anthony Souza

Niki Low

Juan Pablo Frías

Caroline Perez-Dupont

Ravi Upasani

Hanna Cho

Steve Morris

Ramses Erdtmann

Thorsten Kirschberg

Franco Valle

Naomi Cretcher

Heow Tan

The Scientific and Research team at Biomea Fusion, Inc. is dedicated to the discovery and development of irreversible small molecules to treat genetically defined cancers. This team conducts advanced research, collaborates on scientific innovation, and ensures the efficacy and safety of drug candidates through rigorous experimental and analytical processes. Key activities include drug discovery, bioinformatics analysis, medicinal chemistry, and safety pharmacovigilance.

Scientific and Research

Clinical Operations

Directors and Senior Managers

Scientific and Research

About

Team members

Other teams at biomea fusion

Clinical Operations

Directors and Senior Managers